|
|
|
|
Desafos actuales ante las complicaciones relacionadas con colgajos
Los cirujanos analizan algunos de los problemas ms comunes que presentan los colgajos LASIK y cmo tratarlos.Los problemas relacionados con los colgajos despus de una ciruga LASIK son motivo de preocupacin para cualquier cirujano...
|
|
|
Prosthesis Implantation: Reports outline prosthesis implantation research from J.R. Corts-Gonzlez and collea
Reports outline prosthesis implantation research from J.R.Corts-Gonzlez and colleagues New research, 'Have phosphodiesterase-5 inhibitors changed the indications for penile implants,' is the subject of a report. According to...
|
|
|
Honduras confirms first death from A/H1N1 flu
TEGUCIGALPA, June 22 (Xinhua) -- Honduran Health Minister Carlos Aguilar confirmed on Monday the first death from the A/H1N1flu in the country.The patient was a 23-year-old woman from the west of the country and she had six months of...
|
|
|
Kureczka/Martin Associates: ChemGenex's omacetaxine may provide first viable treatment option for highly resis
ChemGenex's omacetaxine may provide first viable treatment option for highly resistant form of CML MELBOURNE, Australia, and MENLO PARK, California U.S.A.(June 1st, 2009) ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) announced...
|
|
|
Accuray's Euan Thomson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Recipient in Northern Califo
Award Recognizes Entrepreneurial Excellence in Health and Life Sciences Category SUNNYVALE, Calif., June 17 /PRNewswire-FirstCall/ -- Accuray Incorporated , a global leader in the field of radiosurgery, announced today that Euan Thomson, Ph....
|
|
|
Honduras confirms 32 new cases of A/H1N1 flu
Chile reports first death from A/H1N1 flu WHO getting closer to declaring A/H1N1 pandemic, says official Nicaragua registers first case of A/H1N1 flu Another Turkish citizen detected with influenza A/H1N1 Israel finds five more A/H1N1 flu...
|
|
|
Honduras confirms 32 new cases of A/H1N1 flu
TEGUCIGALPA, June 2 (Xinhua) -- The Honduran government confirmed on Tuesday 32 new cases of A/H1N1 flu, mostly in the northern parts of the country, bringing the total number of infections to 34.'There have been 32 new confirmed cases,...
|
|
|
First Viable Treatment Option For Highly Resistant Form Of CML May Be Provided By ChemGenex's Omacetaxine
ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) announced that the latest data from its pivotal study of omacetaxine in patients with T315I-positive chronic myeloid leukemia (CML) was the subject of an oral presentation and...
|
|
|
Pivotal Study Results: ChemGenex's Omacetaxine May Provide the First Viable Drug Treatment Option for Patients
Findings Suggest Omacetaxine Offers an Important Breakthrough in the Treatment of CML Patients with the T315I Resistance Mutation MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 1, 2009 - ChemGenex Pharmaceuticals...
|
|
|
BREAKING NEWS UPDATE: Dr. Kenny De Meirleir Announces He has Revealed the True Nature of ME/CFS (Mya
ME/CFS researcher Dr.Kenny De Meirleir, MD, PhD, spoke at a press conference unveiling his team's groundbreaking findings regarding the illness called Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). The presentation...
|
|
|
June 1, 2009
ME/CFS researcher Dr.Kenny De Meirleir, MD, PhD, spoke at a press conference unveiling his team's groundbreaking findings regarding the illness called Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). The presentation...
|
|
|
[Leukemia and Bone Marrow Transplantation] Significance of Increasing Levels of Minimal Residual Disease in Pa
This Article Google Scholar Social Bookmarking Accepted February 11, 2009 Significance of Increasing Levels of Minimal Residual Disease in Patients With Philadelphia ChromosomePositive Chronic Myelogenous Leukemia in Complete Cytogenetic...
|
|
|
Pivotal Study Results: ChemGenexs Omacetaxine May Provide the First Viable Drug Treatment Option for Patien
MELBOURNE, Australia & MENLO PARK, Calif.-(Business Wire)-June 1, 2009 - ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) (NASDAQ:CXSP) announced that the latest data from its pivotal study of omacetaxine in patients with...
|
|
|
Pivotal Study Results: ChemGenexs Omacetaxine May Provide the First Viable Drug Treatment Option for Patien
ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) (NASDAQ:CXSP) announced that the latest data from its pivotal study of omacetaxine in patients with T315I-positive chronic myeloid leukemia (CML) was the subject of an oral presentation...
|
|
|
ChemGenex's omacetaxine may provide first viable treatment option for highly resistant form of CML
MELBOURNE, Australia, and MENLO PARK, California U.S.A.(June 1st, 2009) ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX:CXS) announced that the latest data from its pivotal study of omacetaxine in patients with T315I-positive chronic...
|
|
|
Free Treatment for Breast Cancer Available in Pennsylvania
PA Breast Cancer Coalition holds press conference EPHRATA, Pa., April 29 /PRNewswire-USNewswire/ -- Did you know FREE treatment is available to women diagnosed with breast cancer in Pennsylvania who are uninsured or underinsured?
|
